KPV (Lysine-Proline-Valine) 10 mg is a naturally occurring research compound derived from α-MSH, supplied for laboratory research only. It is studied for its anti-inflammatory and antimicrobial activity in cell and animal models.
Key Aspects of KPV 10 mg
- Research areas: Inflammatory signalling, intestinal epithelial models and skin-related laboratory models.
- Mechanism of interest: Studied for its effect on inflammatory signalling pathways, including NF-κB and TNF expression, in vitro.
- Format: Lyophilised (freeze-dried) powder, 10 mg per vial.
A Small Anti-Inflammatory Research Compound
KPV is the C-terminal research compound of alpha-melanocyte stimulating hormone (α-MSH). It retains much of the anti-inflammatory activity of its parent hormone in laboratory studies without the pigmenting effects, which makes it a focused tool for inflammation research.
Gut and Epithelial Research
Studies in intestinal epithelial cell models have examined how KPV interacts with pro-inflammatory cytokine production through the NF-κB pathway.
Antimicrobial Research
KPV has shown antimicrobial activity against certain bacteria and fungi in laboratory studies.
Quality and Storage
The vial is lyophilised to preserve the amino acid sequence during transport. For long-term storage keep refrigerated at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep chilled and use within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
